2020
DOI: 10.1021/acs.jmedchem.0c01332
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of Novartis’ Small Molecule Screening Deck Design

Abstract: This article summarizes the evolution of the screening deck at the Novartis Institutes for BioMedical Research (NIBR). Historically, the screening deck was an assembly of all available compounds. In 2015, we designed a first deck to facilitate access to diverse subsets with optimized properties. We allocated the compounds as plated subsets on a 2D grid with property based ranking in one dimension and increasing structural redundancy in the other. The learnings from the 2015 screening deck were applied to the d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
55
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2
2

Relationship

3
6

Authors

Journals

citations
Cited by 53 publications
(56 citation statements)
references
References 99 publications
(143 reference statements)
0
55
0
Order By: Relevance
“…Moreover, this approach is also relevant to experimental high-throughput screening, an expensive and important tool for challenging drug discovery problems. 51 Future work will seek to extend the open source MolPAL software package and leverage it in a prospective manner to greatly accelerate a structure-based virtual screen of the Enamine REAL database. We also hope to expand MolPAL beyond the initial software detailed in this report with the addition of new surrogate model architectures, the inclusion of improved uncertainty estimation techniques, and the expansion to other forms of virtual discovery, i.e., other objective functions.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, this approach is also relevant to experimental high-throughput screening, an expensive and important tool for challenging drug discovery problems. 51 Future work will seek to extend the open source MolPAL software package and leverage it in a prospective manner to greatly accelerate a structure-based virtual screen of the Enamine REAL database. We also hope to expand MolPAL beyond the initial software detailed in this report with the addition of new surrogate model architectures, the inclusion of improved uncertainty estimation techniques, and the expansion to other forms of virtual discovery, i.e., other objective functions.…”
Section: Discussionmentioning
confidence: 99%
“…However, the multi-class classification approach of scaffold network is not suitable for fold splitting, thus it was necessary to post-process the output. For practical purposes in medicinal chemistry, scaffolds with three rings often provide a useful level of granularity [26]. Therefore, from the scaffolds generated by the RDKit scaffold network implementation all scaffold with three rings were selected.…”
Section: Scaffold-based Binningmentioning
confidence: 99%
“…However, the multi-class classification approach of scaffold network is not suitable for fold splitting, thus it was necessary to post-process the output. For practical purposes in medicinal chemistry, scaffolds with three rings often provide a useful level of granularity [30]. Therefore, from the scaffolds generated by the RDKit scaffold network implementation all scaffold with three rings were selected.…”
Section: Scaffold-based Binningmentioning
confidence: 99%